| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,946 |
2,752 |
$294K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,340 |
1,263 |
$183K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
322 |
315 |
$42K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
501 |
487 |
$25K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
248 |
242 |
$25K |
| 99072 |
|
1,102 |
1,053 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
154 |
146 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
72 |
61 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
218 |
176 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
15 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
13 |
$2K |
| 92551 |
|
121 |
112 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
61 |
59 |
$991.80 |
| 96127 |
|
102 |
56 |
$572.82 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$421.08 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
12 |
$323.84 |
| 85018 |
|
27 |
26 |
$61.62 |
| 90686 |
|
286 |
281 |
$41.10 |
| 90656 |
|
23 |
23 |
$0.00 |
| 99177 |
|
98 |
96 |
$0.00 |